Reduced exposure to calcineurin inhibitors in renal transplantation

The efficacy and relative effects of four immunosuppressive regimens for transplant recipients are evaluated. Results show that a regimen of daclizumab, mycophenolate mofetil, and corticosteroids in combination with low-dose tacrolimus may be advantageous for renal function, allograft survival, and acute rejection rates.